01971nam a2200349Ia 4500001001200000003000600012005001700018007001400035008004100049040007800090043001200168074001900180088009000199086002300289110009800312245029600410260011400706300002800820336002600848337002700874338003100901504004100932500002600973500003500999500002501034533009401059650004201153650004101195650004701236776017001283776016801453ocm51932040OCoLC20180312141842.0he bmb024bbca030327s2002    dcu     bb   f000 0 eng d  aFPSbengcFPSdOCLCQdFCMBLdOCLCFdOCLCOdOCLCQ.dOCLCOdOCLCQdGPOdMvI  an-us---  a1019-B-01 (MF)  aSerial no. 107-135 (United States. Congress. House. Committee on Energy and Commerce)0 aY 4.C 73/8:107-1351 aUnited States.bCongress.bHouse.bCommittee on Energy and Commerce.bSubcommittee on Health.10aExamining prescription drug importation :ba review of a proposal to allow third parties to reimport prescription drugs : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Seventh Congress, second session, July 25, 2002.  aWashington :bU.S. G.P.O. :bFor sale by the Supt. of Docs., U.S. G.P.O. [Congressional Sales Office],c2002.  aiii, 112 pages ;c24 cm  atextbtxt2rdacontent  amicroformbh2rdamedia  amicrofichebhe2rdacarrier  aIncludes bibliographical references.  a"Serial No. 107-135."  aShipping list no.:2003-0144-M.  aCRDP Program record.  aMicrofiche.bWashington :cSupt. of Docs., U.S. G.P.O.,d2003.e2 microfiches : negative. 0aPharmaceutical policyzUnited States. 0aPrescription pricingzUnited States. 0aDrugsxLaw and legislationzUnited States.08iOnline version:aUnited States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health.tExamining prescription drug importationw(OCoLC)85278375708iPrint version:aUnited States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health.tExamining prescription drug importationw(OCoLC)51390149